Form 8-K · Current report
Ameren 8-K, filed Nov 5, 2026
- Filed
- CIK
- 0001002910
- Accession no.
- 0001002910-26-000030
Summary
Ameren reported third quarter 2026 GAAP diluted earnings per share of $2.42, up from $2.35 a year earlier, and raised its 2026 earnings guidance range to $5.35 to $5.55 per diluted share. The company also set 2027 guidance of $5.70 to $5.90 per diluted share and issued 8% to 10% compound annual EPS growth guidance for 2027 through 2031, supported by $38.1 billion of planned infrastructure investment, with chairman, president and CEO Martin J. Lyons, Jr. citing growing energy demand and economic development in its region.
Key points
- Third quarter 2026 GAAP diluted EPS were $2.42 versus $2.35 in the third quarter of 2025; adjusted EPS were $2.42 versus $2.17.
- Ameren raised its 2026 earnings guidance range to $5.35 to $5.55 per diluted share from $5.25 to $5.45.
- Ameren established 2027 guidance of $5.70 to $5.90 per diluted share and an 8% to 10% EPS compound annual growth rate for 2027 through 2031, off the $5.80 midpoint base.
- The multi-year growth outlook rests on $38.1 billion of planned infrastructure investments and projected rate base growth of about 13.3% compounded annually from 2026 through 2031.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02 Results of Operations and Financial Condition. On November 5, 2026, Ameren Corporation (“Ameren”) issued a press release announcing its earnings for the quarterly period ended September 30, 2026. The press release is attached as Exhibit 99.1 and is incorporated herein by reference. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of Ameren under the Securities Act of 1933, as amended, or the…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.